The impact of quitting smoking on weight among women prisoners participating in a smoking cessation intervention.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2901271)

Published in Am J Public Health on June 17, 2010

Authors

Karen L Cropsey1, Leslie A McClure, Dorothy O Jackson, Gabrielle C Villalobos, Michael F Weaver, Maxine L Stitzer

Author Affiliations

1: Department of Psychiatry, University of Alabama at Birmingham, 35209, USA. kcropsey@beapsy1.his.uab.edu

Articles cited by this

Actual causes of death in the United States, 2000. JAMA (2004) 44.38

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44

Obesity. Lancet (2005) 17.67

Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62

Self-reported health and prior health behaviors of newly admitted correctional inmates. Am J Public Health (2000) 5.13

Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr (2008) 4.82

The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med (1995) 3.39

Smoking among female prisoners: an ignored public health epidemic. Addict Behav (2004) 2.57

Health status of older male prisoners: a comprehensive survey. Am J Public Health (1992) 2.34

Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol (1994) 2.03

Cigarette smoking and diabetes. Prog Cardiovasc Dis (2003) 1.85

Smoking cessation in women concerned about weight. Am J Public Health (1992) 1.79

Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ (2006) 1.65

The role of weight concern and self-efficacy in smoking cessation and weight gain among smokers in a clinic-based cessation program. Addict Behav (1999) 1.61

The effects of a prison smoking ban on smoking behavior and withdrawal symptoms. Addict Behav (2005) 1.58

Tobacco policy in American prisons, 2007. Tob Control (2008) 1.50

Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res (2006) 1.47

Smoking cessation intervention for female prisoners: addressing an urgent public health need. Am J Public Health (2008) 1.35

Waist circumference and weight following smoking cessation in a general population: the Inter99 study. Prev Med (2007) 1.32

Motivational factors related to quitting smoking among prisoners during a smoking ban. Addict Behav (2003) 1.26

Influences of gender and weight gain on short-term relapse to smoking in a cessation trial. J Consult Clin Psychol (2001) 1.20

Smoking status: effects on the dietary intake, physical activity, and body fat of adult men. Am J Clin Nutr (1990) 1.13

Metabolic effects of cigarette smoking. J Appl Physiol (1985) (1992) 1.13

The role of smoking in the regulation of energy balance. Int J Obes (1984) 1.08

Weight concerns and smoking: A literature review. Ann Behav Med (1995) 1.04

Effects of tobacco smoking on caloric intake. Br J Addict (1992) 1.04

An analysis of racial and sex differences for smoking among adolescents in a juvenile correctional center. Drug Alcohol Depend (2007) 0.90

Smoking bans and restrictions in U.S. prisons and jails: consequences for incarcerated women. Am J Prev Med (2009) 0.84

[Smoking cessation and weight gain]. Ann Ig (2007) 0.77

Articles by these authors

Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry (2005) 6.97

Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69

A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev (2010) 5.44

Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry (2006) 4.64

Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol (2011) 4.61

Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis (2008) 3.87

Randomized Trial of Reduced-Nicotine Standards for Cigarettes. N Engl J Med (2015) 3.63

Incident cognitive impairment is elevated in the stroke belt: the REGARDS study. Ann Neurol (2011) 3.06

Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction (2007) 2.84

Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk. Ann Neurol (2008) 2.68

Association of waist circumference and body mass index with all-cause mortality in CKD: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis (2011) 2.49

The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men. Exp Clin Psychopharmacol (2008) 2.44

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med (2006) 2.32

Waterpipe tobacco smoking and cigarette smoking: a direct comparison of toxicant exposure and subjective effects. Nicotine Tob Res (2010) 2.26

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25

ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection? Neurology (2014) 2.08

Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem (2009) 2.03

Contingency management for the treatment of methamphetamine use disorders. Am J Psychiatry (2006) 1.99

Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke (2011) 1.86

Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality. Prev Med (2009) 1.81

A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Exp Clin Psychopharmacol (2002) 1.81

Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes. Stroke (2013) 1.80

A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. J Consult Clin Psychol (2004) 1.76

The association of self-reported neighborhood disorganization and social capital with adolescent alcohol and drug use, dependence, and access to treatment. Drug Alcohol Depend (2007) 1.75

Self-report of stroke, transient ischemic attack, or stroke symptoms and risk of future stroke in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke (2012) 1.74

Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev (2009) 1.74

Kidney function, albuminuria, and all-cause mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study. Am J Kidney Dis (2010) 1.71

Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation (2014) 1.69

Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke (2007) 1.69

Prize-based contingency management does not increase gambling. Drug Alcohol Depend (2006) 1.63

Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2011) 1.63

Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction (2012) 1.62

Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol (2012) 1.60

Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol (2006) 1.59

Cognitive impairment in methadone maintenance patients. Drug Alcohol Depend (2002) 1.56

Pharmacotherapy for nicotine dependence. CA Cancer J Clin (2005) 1.54

Fine particulate matter and incident cognitive impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. PLoS One (2013) 1.53

Imputation of incident events in longitudinal cohort studies. Am J Epidemiol (2011) 1.48

Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD. Am J Kidney Dis (2011) 1.48

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47

Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res (2006) 1.47

Can a school-based hand hygiene program reduce asthma exacerbations among elementary school children? J Allergy Clin Immunol (2012) 1.45

Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun (2004) 1.44

Effect of duration and age at exposure to the Stroke Belt on incident stroke in adulthood. Neurology (2013) 1.43

Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol (2011) 1.42

Population-based fracture risk assessment and osteoporosis treatment disparities by race and gender. J Gen Intern Med (2009) 1.40

Regional differences in diabetes as a possible contributor to the geographic disparity in stroke mortality: the REasons for Geographic And Racial Differences in Stroke Study. Stroke (2008) 1.39

Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemp Clin Trials (2011) 1.38

Poverty and racial disparities in kidney disease: the REGARDS study. Am J Nephrol (2010) 1.38

Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers. Nicotine Tob Res (2008) 1.36

Acute effects of waterpipe tobacco smoking: a double-blind, placebo-control study. Drug Alcohol Depend (2011) 1.34

Experimental evidence for a causal relationship between smoking lapse and relapse. J Abnorm Psychol (2006) 1.30

Differential success rates in racial groups: results of a clinical trial of smoking cessation among female prisoners. Nicotine Tob Res (2009) 1.30

Delay of smoking gratification as a laboratory model of relapse: effects of incentives for not smoking, and relationship with measures of executive function. Behav Pharmacol (2009) 1.29

Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail (2008) 1.28

Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2012) 1.28

An item response theory modeling of alcohol and marijuana dependences: a National Drug Abuse Treatment Clinical Trials Network study. J Stud Alcohol Drugs (2009) 1.27

Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction (2005) 1.25

Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction (2011) 1.22

Management of chronic nonmalignant pain: a needs assessment in an internal medicine resident continuity clinic. J Opioid Manag (2008) 1.22

Utilization of communication technology by patients enrolled in substance abuse treatment. Drug Alcohol Depend (2012) 1.22

Chronic kidney disease is often unrecognized among patients with coronary heart disease: The REGARDS Cohort Study. Am J Nephrol (2008) 1.22

Short- and long-term sunlight radiation and stroke incidence. Ann Neurol (2012) 1.21

Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend (2005) 1.21

Effects of cigarette nicotine content and smoking pace on subsequent craving and smoking. Psychopharmacology (Berl) (2002) 1.19

Opioid abuse and cognitive performance. Drug Alcohol Depend (2004) 1.17

Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders. Drug Alcohol Depend (2008) 1.16

Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol (2012) 1.16

The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend (2012) 1.14

Calculating Cornell voltage from nonstandard chest electrode recording site in the Reasons for Geographic And Racial Differences in Stroke study. J Electrocardiol (2009) 1.14

Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl (2002) 1.14

Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study: baseline results. Kidney Int (2005) 1.13

The construct and measurement equivalence of cocaine and opioid dependences: a National Drug Abuse Treatment Clinical Trials Network (CTN) study. Drug Alcohol Depend (2009) 1.13

Care seeking after stroke symptoms. Ann Neurol (2008) 1.12

Identifying pregnant women at risk for early attrition from substance abuse treatment. J Subst Abuse Treat (2004) 1.10

High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology (Berl) (2002) 1.09

Nurse care manager collaboration with community-based physicians providing diabetes care: a randomized controlled trial. Diabetes Educ (2007) 1.08

Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07

Use of a low-cost incentive intervention to improve counseling attendance among methadone-maintained patients. J Subst Abuse Treat (2005) 1.07

Correlates of anemia in American blacks and whites: the REGARDS Renal Ancillary Study. Am J Epidemiol (2008) 1.06

Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine Tob Res (2012) 1.05

Correlates of stimulant treatment outcome across treatment modalities. Am J Drug Alcohol Abuse (2009) 1.05

Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth. J Am Acad Child Adolesc Psychiatry (2011) 1.05

Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school-based supervised asthma therapy. Pediatrics (2009) 1.04

Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl) (2003) 1.04

The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use. Addiction (2010) 1.03

Addiction and pain. Am J Addict (2003) 1.03

Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study. Am J Addict (2009) 1.03

Blood pressure and stroke in heart failure in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke (2009) 1.02

Changes in environmental tobacco smoke exposure and asthma morbidity among urban school children. Chest (2008) 1.00

Using virtual reality to train children in safe street-crossing skills. Inj Prev (2010) 0.99

Effect of sunlight exposure on cognitive function among depressed and non-depressed participants: a REGARDS cross-sectional study. Environ Health (2009) 0.99

Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav (2002) 0.98

C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study. Stroke (2014) 0.97

Using a latent variable approach to inform gender and racial/ethnic differences in cocaine dependence: a National Drug Abuse Treatment Clinical Trials Network study. J Subst Abuse Treat (2010) 0.97

Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug Alcohol Depend (2002) 0.97

Trust in physicians and blood pressure control in blacks and whites being treated for hypertension in the REGARDS study. Ethn Dis (2010) 0.97